PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Hongfang Li1 Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City;2 Department of Gynecology, The First Hospital of Lanzhou University, Lanzhou

Gaogao Sun1 Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City

Chang Liu2 Department of Gynecology, The First Hospital of Lanzhou University, Lanzhou

Jing Wang3 Department of Gynecology, Longhua District People’s Hospital of Shenzhen City, Shenzhen;4 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Rong Jing5 Department of Gynecology, Tianjin Fifth Central Hospital, Tianjin, People’s Republic of China

Jie Wang3 Department of Gynecology, Longhua District People’s Hospital of Shenzhen City, Shenzhen;4 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Xiaohuan Zhao1 Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City

Xiaoyan Xu1 Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City

Yongxiu Yang1 Department of Obstetrics and Gynecology, The First People’s Hospital of Lanzhou City;2 Department of Gynecology, The First Hospital of Lanzhou University, LanzhouCorrespondence[email protected]

show all

PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date